Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis

BACKGROUND: Sarcomas constitute a heterogeneous group of tumors with different clinical behaviors and variable responses to systemic therapies. Recent immunotherapy studies with PD1 inhibitors (PD1i) show promising results with use in certain soft-tissue sarcomas; however, the clinical and molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiroga, Dionisia, Liebner, David A., Philippon, Jennifer S., Hoffman, Sarah, Tan, Yubo, Chen, James L., Lenobel, Scott, Wakely, Paul E., Pollock, Raphael, Tinoco, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275332/
https://www.ncbi.nlm.nih.gov/pubmed/32503455
http://dx.doi.org/10.1186/s12885-020-07021-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275332/
https://www.ncbi.nlm.nih.gov/pubmed/32503455
http://dx.doi.org/10.1186/s12885-020-07021-x

Ejemplares similares